Regulatory
Regulatory capability integrates regulatory science, quality systems, and approvals strategy to translate preclinical and clinical evidence into FDA and DoD-authorized medical products. It addresses device, biologic, diagnostic, and combination products for austere, prolonged-field, and combat casualty applications while ensuring safety, labeling, and logistics compliance.
Technical Challenges
Compressed timelines for battlefield needs versus standard regulatory review cycles
Designing clinical trials that reflect polytrauma, blast injuries, and prolonged field care constraints
Demonstrating product performance in austere environments (temperature, vibration, contamination)
Integrating cybersecurity, interoperability, and human factors into clearance pathways
Generating relevant real-world evidence (RWE) for rare or emergent military injury patterns
Emerging Opportunities
Validated surrogate endpoints and adaptive trial frameworks tailored to combat trauma
Regulatory pathways for combination products and rapidly deployable biologics (e.g., vaccines, therapeutics)
Standards and guidance for long-term durability, transport stability, and field maintenance
Harmonized military–civilian data standards to accelerate post-market surveillance and RWE
Current and Emerging Technologies in Regulatory
Regulatory science and outcome modeling
Computational modeling, Bayesian and adaptive designs, and validated surrogate endpoints to reduce trial duration and size while preserving safety and statistical rigor for trauma and infectious disease interventions.
Digital submission and workflow platforms
Secure e-submissions, electronic Common Technical Document (eCTD) workflows, and automated regulatory intelligence accelerate interactions with FDA, DoD reviewers, and IRBs.
Real-World Evidence & post-market surveillance
Integration of EMR, registries, wearable sensors, and field-reported outcomes enables timely safety signal detection, performance monitoring in prolonged field care, and lifecycle regulatory submissions.
Quality systems and cyber-physical compliance
Automated quality-management, manufacturing process controls, and embedded cybersecurity risk management for connected devices ensure regulatory readiness for deployment under operational conditions.
Importance to Military Medicine
Accelerated availability for combat casualty care
Regulatory strategies (EUA, IDE, streamlined 510(k)/PMA interactions) enable rapid fielding of hemorrhage control, resuscitation, and diagnostic tools when evacuation is delayed.
Enabling prolonged and distributed care
Approval pathways that account for austere environmental testing, portability, and maintenance support durable solutions for far-forward or prolonged care scenarios.
Force readiness and supply assurance
Regulatory compliance underpins logistics, stockpiling, and contingency use of medical countermeasures, preserving force health protection in CBRN and infectious threats.
Safety, interoperability, and lifecycle stewardship
Robust post-market surveillance and human-factors validation reduce harm from device failure or misuse in high-stress operational contexts.
Alignment with the MTEC Mission
Supports MTEC’s DoD mission by accelerating translation of military-relevant medical technologies into authorized use while preserving rigorous safety and effectiveness standards.
Enables dual-use impact—advancing civilian public health and commercial adoption of battlefield-proven innovations.
Bridges multidisciplinary teams—clinical, engineering, regulatory, and logistics—to meet DoD readiness priorities and threat-agnostic preparedness.
Leverages consortium agility to pilot regulatory innovations (adaptive trials, RWE) that standard pathways can later adopt.
Dual-Use (Military + Civilian) Applications
Dual-use examples include trauma hemostatics, tele-critical care platforms, rapid diagnostics, and vaccines—where military validation accelerates civilian deployment and vice versa.
Post-market surveillance frameworks developed for deployed settings inform civilian public-health responses and commercialization safety dossiers.
Explore MTEC Members with Regulatory Capabilities
MTEC members bring regulatory affairs expertise, clinical trial networks, quality and manufacturing experience, and access to operational test beds to de-risk approvals for warfighter needs.
Consortium collaboration accelerates evidence generation, aligns studies with DoD operational realities, and shortens the path from prototype to authorized use.
Explore member profiles to identify partners with regulatory strategy, clinical operations, manufacturing scale-up, and post-market surveillance capabilities to advance military-relevant medical technologies.
81 Members with Regulatory capabilities.

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Danforth Advisors is a strategic and operational consulting firm dedicated to supporting life science companies. They provide a comprehensive range of services tailored to the unique needs of biotech and pharmaceutical companies, from operational finance and accounting to clinical development and regulatory affairs. Their mission is to empower clients with expert guidance and flexible solutions that advance scientific innovation and drive business success.
ERP International is a trusted provider of health and technology solutions, specializing in serving federal civilian and defense agencies. Founded in 2006, the company focuses on enhancing mission performance through innovative staffing, technology solutions, and business process management, all while maintaining a commitment to excellence and community engagement.

Deloitte is a leading global provider of audit, consulting, tax, and advisory services. The company is committed to improving public outcomes through a focus on people and developing relevant, timely, and sustainable solutions for clients. Deloitte's mission is to lead with purpose and drive positive change for people and communities, with a strong emphasis on social impact, sustainability, equity, and trust. Deloitte is also dedicated to helping the power, utilities, and renewables industry grow to become more sustainable, safe, and efficient, and is a fierce champion of industrials, inspiring optimism for the future.

The Conafay Group specializes in representing life sciences companies, universities, and other organizations in the biomedical space before the federal government and associated stakeholders. Since 2004, they have been helping clients advance their research and policy goals by leveraging federal government resources and building strong coalitions.

LaCire is a consulting firm dedicated to empowering innovators, changemakers, and organizations by providing expert-level operations, human capital management, and business development services. With a mission to maximize the power of the innovator, LaCire helps clients build strong foundations for sustainable growth, focusing on ethical standards, flexibility, and collaboration. The company specializes in supporting women- and minority-owned businesses, nonprofits, startups, and international organizations seeking to establish or expand their presence in the U.S. LaCire's experienced team offers tailored solutions in operations, finance, government contracting, communications, and more, enabling clients to achieve authentic, long-term success.
Booz Allen Hamilton is a leading management and technology consulting firm with over 110 years of experience. The company is dedicated to empowering people to change the world through innovative solutions in various sectors including cybersecurity, artificial intelligence, engineering, and defense. Booz Allen partners with government and commercial clients to tackle their most complex challenges, leveraging a culture of innovation and a commitment to excellence. The firm operates with core values of integrity, courage, service, ingenuity, and a commitment to diversity and inclusion.

Harmac is a global contract design and manufacturing organization specializing in single-use medical devices. With over four decades of experience, Harmac provides comprehensive services including product design and development, advanced manufacturing, automation, value engineering, quality assurance, and packaging and sterilization. The company is known for its operational excellence, regulatory compliance, and commitment to sustainability and community engagement. Harmac operates facilities across the United States, Ireland, and Mexico, supporting customers worldwide and across a range of clinical applications.

Clinical Research Strategies (CRS) is a Pittsburgh-based contract research organization and executive management consultancy dedicated to improving the performance of start-up and mid-size life sciences companies. With a focus on instilling fiscal discipline and reducing risks in clinical development, corporate affairs, and quality assurance programs, CRS provides tailored consulting and staffing solutions to navigate the complexities of regulatory pathways and ensure successful product launches. CRS is also committed to leveraging advancements in artificial intelligence and machine learning to enhance clinical research and regulatory processes.

PinMed, Inc., is a National Innovation Award-winning bioinformatics/medical-device company that develops high-fidelity cardiovascular monitoring systems, personalized (adaptive) software, and integrated systems and custom solutions for tracking cardiovascular data in the most challenging environments (e.g., intensive activity, extreme electromagnetic interference, and interventional cardiovascular procedures) and identifying subtle but clinically important indicators of cardiovascular events. PinMed’s award-winning solutions include versatile, multisensor, high-fidelity monitoring systems for various hospital and ambulatory settings. The company has extensive experience in electronic and mechanical engineering, development of software and firmware for various processors, computational modeling, and cardiovascular physiology. PinMed’s flagship mobile platform, PELEX, provides unparalleled versatility in physiological monitoring and has been cleared by the FDA for diagnostic 12-lead ECG testing and various types of ambulatory monitoring.

DLH delivers improved health and national security readiness solutions for federal programs through science research and development, systems engineering and integration, and digital transformation. With over 3,200 employees, DLH is committed to solving complex problems faced by civilian and military customers, leveraging advanced technologies and methodologies to enhance health outcomes and operational readiness.

Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.

Exponent is a multidisciplinary science and engineering consulting firm serving sectors including healthcare, energy, manufacturing, and consumer products. From medical devices, pharmaceuticals, and supplements to digital health and wearables, we deliver rigorous science that quantifies impacts on human health. Exponent helps you push the envelope on the development, deployment, safety, and effectiveness of cutting-edge drugs, devices, and diagnostics — concomitantly balancing benefits and risks. Count on our multidisciplinary, data-driven, evidence-based assessments to give you clarity on your most complex product needs and challenges. With lives on the line, innovations that support healthcare demand the highest levels of scientific rigor. Whether you’re developing a novel drug, a sturdier stent, or a faster flu test, you need clear answers to complex questions, quickly. Exponent supports our life sciences clients across the total product lifecycle by solving critical design, regulatory, safety, and market access challenges. We can collaborate with you throughout your journey, helping you navigate risks and opportunities — and optimize outcomes — with science-based strategies and specialized expertise.

Kaléo is a global leader in drug-delivery device technology and auto-injector innovation, providing millions of patients with security and peace of mind. Our patented Aerio™ platform, with unmatched capabilities and human factors engineering, powers our portfolio of auto-injector products, as well as products under development for third parties.

PPD, a clinical research business of Thermo Fisher Scientific, is a leading provider of global contract research organization (CRO) solutions. The company is dedicated to helping clients accelerate the development of life-changing therapies through comprehensive drug development, laboratory, and lifecycle services. With a commitment to operational excellence and innovative technology, PPD empowers its customers to bring therapies to market faster and improve patient health. PPD has been recognized as an industry leader in clinical development digital transformation services and patient engagement digital transformation. With over 30 years of clinical leadership and a workforce of more than 30,000 employees globally, PPD has conducted over 2,100 trials in the past five years.

Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI